Curriculum Vitae

Transmissible Spongiform Encephalopathies Advisory Committee

Glenn Christopher Telling , BA (Oxon.), MA (Oxon.), PhD
Professor of Microbiology, Immunology and Molecular Genetics

I. BIOGRAPHICAL INFORMATION

A. Education and Research Training

Undergraduate	Corpus Christi College, Oxford University, B.A. (Honors), Biochemistry, ----
Graduate	Oxford University, M.A., Biochemistry, ---- Carnegie Mellon University - Ph.D. Biological Sciences, ---- Summer Research Fellow : Insertion mutagenesis of the vacuolar protease PRPB gene of Saccharomyces cerevisiae using the γδ transposon. Advisor - Elizabeth Jones, Ph.D., Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA Doctoral Thesis : ‘ Genetic analysis of the functions of the adenovirus E1 proteins in oncogenic transformation and lytic infection'. Advisor - James F. Williams, Ph.D., Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA
*Postgraduate*	Jim Williams' Lab, Department of Biological Sciences, Carnegie Mellon University, Pittsburgh 1990-1991 Postdoctoral Fellow Stanley Prusiner's Lab , Department of Neurology, University of California, San Francisco 1991-1994 Postdoctoral Fellow

B. Academic Appointments

Current Appointments at the University of Kentucky
2007 - present	Professor of Microbiology, Immunology & Molecular Genetics(Primary Appointment) Professor of Neurology (Joint Appointment) Graduate Center for Gerontology ( Faculty Affiliate) Sanders-Brown Center on Aging ( Faculty Affiliate)
Other Current Appointments
1998 - present	Department of Pathology, Colorado State University (Faculty Affiliate)
2005 - present	Institute of Biological Sciences/Technology, Beijing Jiaotong University, China (Honorary Visiting Professor)
Previous Appointments
1994-1996	Assistant Research Molecular Biologist, Department of Neurology, University of California, San Francisco
1996-1997	Assistant Professor, Department of Neurology, University of California, San Francisco
1997-1999	Senior Research Scientist and Program Leader, Medical Research Council (MRC) Prion Unit, Imperial College School of Medicine, St. Mary's Hospital, London
1999-2000	Assistant Professor, Department of Microbiology and Immunology, University of Kentucky Assistant Professor, Program in Gerontology, University of Kentucky
2000-2001	Assistant Professor, Department of Neurology, University of Kentucky
2001-2007	Associate Professor , Department of Microbiology, Immunology and Molecular Genetics, University of Kentucky Associate Professor, Department of Neurology, University of Kentucky Associate Professor - Faculty Affiliate, Graduate Center for Gerontology, University of Kentucky
2002 - 2007	Associate Professor, Sanders-Brown Center on Aging, University of Kentucky

C. Honors and Awards

1991-1994	NIH Postdoctoral Fellowship
1996 -1997	Alexander von Humboldt-Stiftung, German American Academic Council Foundation Research Award in Support of Young Scientists and Scholars from the United States and Germany
1999	University of Kentucky research challenge trust fund faculty (RCTF) appointee
2005	Faculty participant in the University of Kentucky - Shandong University ( China) faculty exchange program
2005 - present	Honorary Visiting Professor, Institute of Biological Sciences and Technology, Beijing Jiaotong University, China
2007	Recipient of the Japan Society for the Promotion of Science (JSPS) Invitation Fellowship for Research in Japan

D. Professional Societies

American Society for Microbiology
American Society for Cell Biology
American Association for the Advancement of Science
Federation of American Societies for Experimental Biology
American Society for Biochemistry and Molecular Biology

II. PROFESSIONAL ACTIVITIES

A. Review Activity, Funding Agencies (National and International)
2007 - present	Permanent full member of the Cellular and Molecular Neurodegeneration (CMND) Study Section, National Institutes of Health (NIH)
2006 - 2007	Member of the Neural Degenerative Disorders and Glial Biology Study Section, National Institutes of Health (NIH)
2006	Member of the Neural Oxidative Metabolism and Death Study Section, National Institutes of Health (NIH)
2006	Member of the Alzheimer's disease clinical scientist development "Markey" K08 award review committee
2006	Member of the ZRG1 IDM-Q (10) B Special Emphasis Panel Study Section
2006	Member of the United Kingdom Food Standards Agency (FSA) review panel of Transmissible Spongiform Encephalopathies (TSEs) Program
2005	Member of the NIH/National Institute of Allergy and Infectious Diseases (NIAID) Special Emphasis Panel Review Group ZAI1 ML-I (M1) to review Michael E. Lamm's unsolicited PO1 "Mucosal Immunity and Infection"
2005	Member of the Infectious Diseases and Microbiology IRG Center for Scientific Review Special Emphasis Panel ZRG1 IDM-B, National Institutes of Health (NIH)
2004	Member of the NIH/National Institutes on Aging (NIA) Special Emphasis Panel/Scientific Review Group 2005/01 ZAG1 ZIJ-7 (J1) to review Dr. Stanley Prusiner's P01 " Molecular Pathogenesis of Age-Dependent CNS Degeneration" , University of California, San Francisco
2004	Member of Special Emphasis Panel (BDCN-E 02) of the Brain Disorders and Clinical Neuroscience integrated review group, National Institutes of Health (NIH)
2003	Reviewer for the ZNS1 SRB-W (01) Fogarty Adults Special Emphasis Panel "Brain Disorders in the Developing World: Research across the Lifespan", National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH)
2001- 2004	Member of the Brain Disorders and Clinical Neuroscience's Study Section-3 (BDCN-3) , National Institutes of Health (NIH)
2002	Member of the United States Army Medical Research and Development Command, Program in Prion Research Study Section
2002	Member of Site Visiting Committee to review Dr. Stanley Prusiner's NIH National Institutes on Aging (NIA) Program Project Grant, ‘Novel therapeutics for prion diseases', University of California, San Francisco
2002	Member of the Site Visiting Committee to review future Biological Sciences Research Council (BBSRC) -sponsored TSE research at the Institute for Animal Health, UK
2001	Chair, Sub-committee to review Transmissible Spongiform Encephalopathies Programs: Biological Sciences Research Council (BBSRC) 2001 Institute Assessment Exercise
2001	Member of the Site Visiting Committee to review research at the Institute for Animal Health, UK, for allocation of the 2002-2006 Competitive Strategic Grant for the UK Biotechnology and Biological Sciences Research Council (BBSRC) 2001 Institute Assessment Exercise
1999	Member of the scientific advisory panel for the UK Ministry of Agriculture Food and Fisheries (MAFF) Transmissible Spongiform Encephalopathies (TSE) research and surveillance program
1998-1999	Member of the UK Biotechnology and Biological Sciences Research Council (BBSRC) biology of spongiform encephalopathies program (BSEP) research funding advisory panel
1994-present	Ad hoc referee for the following funding agencies: US Alzheimer's disease and Related Disorders; National Institutes of Health (NIH); National Science Foundation (NSF); UK Medical Research Council (MRC); Comitato Promotore Telethon (Italy) research grants; Special Trustees for St Thomas' Hospital Research Endowments Committee; UK Biotechnology and Biological Sciences Research Council (BBSRC) UK Ministry of Agriculture Food and Fisheries (MAFF); Indiana Alzheimer Disease Center; UK Department of Health; Science Foundation Ireland; Alberta Agricultural Research Institute
B. Membership of other scientific committees, advisory panels and consultancies
2006 - 2009	Chair of the United States Food and Drug Administration (FDA) Transmissible Spongiform Encephalopathy Advisory Committee (TSEAC)
2005 - 2006	Member of the United States Food and Drug Administration (FDA) Transmissible Spongiform Encephalopathy Advisory Committee (TSEAC)
2006	Advisor to the European Commission Prion Strain Typing Expert Group
2005	Advisor to the World Health Organization (WHO) on Transmissible Spongiform Encephalopathies
2005	Member of the United States Food and Drug Administration (FDA) Center for Devices and Radiological Health advisory panel to address TSE decontamination studies for medical devices
2004 - 2007	Member of the United States Food and Drug Administration (FDA) Transmissible Spongiform Encephalopathy Advisory Committee (TSEAC)
2004 - present	Member of the TSE task force, Kentucky Department of Agriculture
2004	Consultant to the Food and Drug Administration (FDA) Transmissible Spongiform Encephalopathy Advisory Committee (TSEAC)
1999-2000	Member of the steering committee for the UK Biotechnology and Biological Sciences Research Council (BBSRC) , Ministry of Agriculture Food and Fisheries (MAFF), Medical Research Council (MRC) and Department of Health sponsored Transmissible Spongiform Encephalopathies (TSE) workshop, April 2000
1996	Ad Hoc committee member to provide information bearing on the risk of the transmission of Creutzfeldt-Jakob disease from the administration of blood, blood components, or blood derivatives: United States Food and Drug Administration (FDA) and the National Institutes of Health (NIH) National Heart, Lung and Blood Institute (NHLBI)
1996-1999	Member of the organizing committees for the 3rd, 4th and 5th Annual German-American Frontiers of Science Symposium: National Academy of Sciences (NAS), the Max-Planck-Society and the German American Academic Council (GAAC)
2002	Member of the committee to develop an NIH-Sponsored TSE Reagent Repository Workshop
2001	Member of the scientific advisory panel for the US Creutzfeldt-Jakob Disease Foundation
2000- present	Member of the External Advisory Committee for the Indiana Alzheimer Disease Center
2006	Member of the vCJD Scientific Advisory Committee, ------------
2004	Scientific consultant to -------------------------------------
2002	Consultant, Scientific advisory meeting: proteasome inhibition and prion disease. -------- ------------------------------------------
2002	Scientific consultant to --------------------------------------
2002	Member of the CWD advisory panel, Kentucky Department of Fish and Wildlife Resources
2001- present	Scientific consultant to --------------------------
2000	Scientific consultant to the law firms of ---------------------------------------------------------- --------------------------------------------
2006 - 2007	Scientific consultant to the law firm of ----------------------
1998	Scientific consultant to the law firm of -------------------------------------------- Risks of infectivity of a TSE/BSE agent associated with proteins isolated from the milk of transgenic animals
C. Editorial Responsibilities
2005 - present	Science - Board of Reviewing Editors
2007	Biochimica et Biophysica Acta - Guest Editor for the 'Prion-Related Disorders' issue of the Molecular Basis of Disease series
2006 - present	Prion - Associate Editor
2004	Prions and Prion Diseases: Current Perspectives. Glenn C. Telling (Ed.) Horizon Scientific Press, Wymondham UK
*D. Ad hoc* journal reviewing**
	On average, 10 to 12 additional manuscripts reviewed per year Science; Nature ; Nature Medicine ; EMBO Journal ; Journal of General Virology ; Neurology; Molecular Reproduction; Brain Research; Journal of the Royal College of Physicians of London; Journal of Clinical Pathology; Journal of Neurochemistry; Royal Society Proceedings: Biological Sciences; Neuroscience Letters; Molecular Medicine Today; American Journal of Pathology; Trends in Neurosciences; Lancet; Biochemistry; Trends in Cell Biology; Proceedings of the National Academy of Sciences (PNAS); Trends in Microbiology; Journal of Biological Chemistry; Neuropathology and Applied Neurobiology; Journal of Neuroscience; Journal of Thrombosis and Haemostasis; Molecular Brain Research; FEBS Letters; Journal of Virology; Lancet, Neurology; PLOS Pathogens; Annals of Neurology; Nature Neuroscience; Molecular Biology of the Cell; Journal of Pathology
E. Organization of workshops and meeting sessions
1997	National Academy of Sciences (NAS), Max-Planck-Society and the German American Academic Council's 3rd Annual German-American Frontiers of Science Symposium, Munich, Germany
1998	National Academy of Sciences (NAS) and the German American Academic Council's 4th Annual German-American Frontiers of Science Symposium, Irvine. California
1999	National Academy of Sciences (NAS) and the German American Academic Council's 5th Annual German-American Frontiers of Science Symposium: Potsdam, Germany
2000	Biotechnology and Biological Sciences Research Council (BBSRC) Biology of Spongiform Encephalopathies (BSEP) Workshop , Keele, UK
2005	Second International Chronic Wasting Disease Symposium, Madison, Wisconsin

III. EDUCATIONAL ACTIVITIES

A. Courses Taught
2005	GEO475G Medical Geography
2007 - present	Instructor, MI710-02 Mechanisms of Microbial Pathogenesis
2004 - present	Instructor, MI615: Molecular Biology
2004 - present	Instructor, MI710-002: Molecular Virology
2000 - 2003	GRN650, Research Methods in Gerontology (Course Director)
1999 - present	GRN650, Research Methods in Gerontology, Transgenic methods in aging research
2000 - present	Instructor, MI822: Infection, Immunity and Disease Lectures: Viral Genetics; Prions and Diseases Dicussion Groups: Childhood Viral Diseases; Vector-borne viruses
1999	PGY618: Molecular Neurobiology, Prions and Prion Diseases
2000 - present	MI772, Seminar in Microbiology
2002	Organizer of the Cellular and Molecular Mechanisms of Neurodegenerative Diseases Journal Club
2007 - present	Organizer of the Microbiology, Immunology and Molecular Genetics Departmental Prion Diseases Journal Club Mentored MI772 Students (Seminar in Microbiology) - ----------------- (2000) ; ------------- ---------- (2007)
2005	Medical School of Shandong University, China - Course on Prions and Prion diseases for medical students
	Prior to the University of Kentucky
1997	Visiting lecturer, University of California, Berkeley
1997	Visiting lecturer, University Pacific School of Dentistry, San Francisco
1996 - 1997	Organizing teaching seminars for a group that included 20 postdoctoral fellows, Department of Neurology, University of California, San Francisco
1998	Lecturer, B.Sc. Clinical Sciences and M.Sc. Molecular Genetics, Imperial College School of Medicine, St. Mary's Hospital, London
B. Previously mentored Research Fellows and Associates
1996 - 1997	-----------------. - Postdoctoral Fellow, University of California, San Francisco
1996 - 1997	------------------ - Research Associate, University of California, San Francisco
1997 - 1999	----------------- - Research Associate, MRC Prion Unit London
1997 - 1999	----------------- - Research Associate, MRC Prion Unit London
1999 - 2001	------------------ - Research Associate, University of Kentucky
2001	------------------- - Postdoctoral Fellow, University of Kentucky
2002 - 2005	--------- - Postdoctoral Fellow, University of Kentucky
2002 - 2003	------------, Associate Professor, Laboratory of Molecular Biology, Shandong University School of Medicine - Visiting Scientist, University of Kentucky
2001 - 2003	--------------- - Research Associate, University of Kentucky
C. Previously mentored Graduate Students Graduate Degree/Date Thesis title Current position
------------------ MS (2001) -------------------------------- -------------------------------------------- --------------------------- ------------------------------ -------------------------------------------- -----
---------------- PhD (2005) -------------------------- --------------------------------------------- ------------------ -------------------------------------- --------------------------------------- --------------------------------- --------------------------- -----------------------------
---------------- PhD (2005) --------------------------------------- ------------------------------------------- ---------------------------------------------------------------------------------- -------------------------------------- ------------------------------------ --------------------------------------
-------------- MS (2003) ---------------------- -----------
D. Rotation project advisor
	------------------------- ---------------------- ----------------------- -------------------------- -------------------- --------------------- --------------- -------------------------- ----------------------- ---------------------- ------------------------- ---------------------- ---------------------- --------------- ---------------- -------------------- ----------------------- ------------------------ ---------------- --------------------- ----------------- --------------------------- ------------------------ -------------------------- ----------------------------- ---------------- ---------------------- -------------------------- --------------------------- -------------
E. Current Graduate Students
	------------------------------------------------------------------------
F. Current Postdoctoral Fellows and Research Staff
2005 - present	------------------------------------
2006 - present	-----------------------------------
2002 - present	------------------------------------
2005 - present	--------------------------------------
2006 - present	---------------------------------
2006 - present	------------------------------------
G. Other graduate student committees at University of Kentucky
2002 - 2005	-------------------------------------------------------------------------------------
2002- 2004	-------------------------------------------------------------------------------------
2002- 2006	-------------------------------------------------------
2006	---------------------------------------------------
2006	--------------------------------------------------
2006	--------------------------------------------------------------------
2006 - present	-------------------------------------------------------------------
H. External Thesis Committees
1997-2001	------------------------------ College of Veterinary Medicine and Biomedical Sciences, Department of Pathology, Colorado State University
2002- 2006	---------------------------- University of Rochester , Center for Aging and Developmental Biology , Division of Gene Therapy and Molecular Medicine
I. Mentored Undergraduate and High School Students
2003	------------------ University of Kentucky - "Bucks for Brains" research student advisor
2006 - 2007	-----------------, Agricultural Biotechnology Research Mentor
2007	----------------

IV. UNIVERSITY SERVICE

2004	Chair, Cellular and Molecular Biology of Prion Diseases Faculty Search Committee
2002	Chair, Search Committee for Chair of the Department of Physiology
2001- 2003	Chair, Recruitment Committee, Graduate Program in Gerontology
2000	Chair, Ad hoc committee to review research proposals for the Spinal Cord and Brain Injury Research Center, College of Medicine
2007 - 2010	Member of the University of Kentucky Senate
2006 - 2007	University of Kentucky Vice President for Research Search Committee
2006 - present	Microbiology, Immunology and Molecular Genetics Education, Practice and Policies Committee
2006 - present	College of Medicine Dean's Research Advisory Affairs Group (RAAG)
2005 - 2006	Department of Internal Medicine Six Year Review Committee
2006	College of Medicine, Ad hoc promotion and tenure advisory committee
2005 - 2006	Gerontology faculty search committee
2005 - 2008	Professional Code Committee
2005 - present	Transgenic Facility Oversight Committee
2004 - present	University Mouse Focus Group
2003 - present	University Research Advisory Committee
2004 - 2007	Administrative Council for the Program in Gerontology
2002 - 2005	Institutional Biosafety Committee
2001- 2004	Steering Committee, Graduate Program in Gerontology
2002	Planning Committee to establish a Regional Center of Excellence in Emerging Diseases at the University of Kentucky
2000 - 2001	Recruitment Committee, Graduate Program in Gerontology Imperial College School of Medicine, London
1997-1999	Division of Neuroscience representative, Computer Users Consultative Committee University of California, San Francisco
1994-1996	Co-ordination of scientific aspects of Licensing and Research Agreement:----------------- ---------------------------- ------------------------- ---------------------------------- -----------------------------
1994-1997	Producing Patent Applications in liaison with patent lawyers and the University Of California Office Of Technology Transfer
1994-1997	Co-ordination of scientific and budgetary aspects of extra-mural grants and non-competitive grant renewals
1996-1997	Co-ordination of Annual Progress Reports for -------------------- ------------------------------------- ------------------------ ----------------------------------------- -----------------------------------
1997	Planning Committee for Annual Review of ------------------ ------------------------ ------------------------- --------------------- -----------------------

V. RESEARCH ACTIVITIES

A. Active Support
2002 - 2009	N01-AI-25491 Co-Principal Investigator (30 % effort) US Based Collaboration in Emerging Viral and Prion Diseases NIAID/NIH $2,634,349
2005 - 2010	2RO1 NS040334-04 Principal Investigator (40 % effort) Transgenetic studies of prion disease in cervids NINDS/NIAID/NIH $1,678,035
2002 - 2007	V180003 Co-Investigator ( 10 % effort) Genetic susceptibility and biological characterization of CWD United States Department of Defense (DoD) $ 743,282
2006 - 2011	58-5348-6-131 Principal Investigator (0 % effort) Specific Cooperative Agreement U.S. Department of Agriculture (USDA) Agricultural Research Service $425,000
2007 - 2009	Principal Investigator ( 5 % effort) Specific Cooperative Agreement U.S. Department of Agriculture (USDA) Agricultural Research Service $ 78 ,0 49
2006 - 2007	T32 AI49795 Training Faculty Member (for Kristi Green) Training Program in Microbial Pathogenesis NIH $18,156/year
2007 - 2008	T32 DA022738 Training Faculty Member (for Rachel Angers) Therapeutic Strategies for Neurodegeneration NIH $25,370/year
B. Previous Support
2002 - 2005	Agreement with Institute of Animal Health to make transgenic mice $120,834
2001 - 2003	3 R01 NS40334-02S1 Principal Investigator Transgenetic studies of prion disease in cervids (Supplement) NINDS/NIAID/NIH $750,000
2003	Agreement with ------------------- -------------
2000 - 2001	------------ Principal Investigator ----------------------------- --------------------------- ---------------------------- ------------------------------- --------------------------------- -------------
2001 - 2006	T32 AI49795 Training Faculty Member (for Shawn Browning) Training Program in Microbial Pathogenesis NIH $18, 156/year
1999 - 2000	Principal Investigator NIH Academic Leadership Award and the Office of the Vice Chancellor for Research and Graduate Studies for the University of Kentucky Medical Center $15, 000
2002 - 2004	Training Faculty Member (for Michael Jernigan) Molecular and Cellular Aspects of Brain Aging NIA/NIH $19, 656/year
1997 - 2002	Principal Investigator --------------------------- -------------------

C. Publications

United States and International Patents

Telling, Glenn C. "Transgenic mice for bioassay of prions from deer or elk with chronic wasting disease" United States Patent Application, provisional application submitted to US Patent Office, November 2005
Telling, Glenn C. and Rodney Guttmann "Calpains as targets for inhibition of prion disease"

United States Patent Application 20060234971, October 2006

Prusiner, Stanley B; Glenn C. Telling; Fred E Cohen; Michael R. Scott "Recombinant Construct Encoding Epitope Tagged PrP Protein"

United States Patent 6,602,672. Issued August 5, 2003

Prusiner, Stanley B; Glenn C. Telling; Fred E Cohen; Michael R. Scott "Transgenic animals expressing artificial epitope-tagged proteins"

United States Patent 5,789,655. Issued August 8, 1998
United States Patent 6,150,583. Issued November 21, 2000

Prusiner, Stanley B.; Michael R. Scott; Glenn C. Telling " Detecting cow, sheep and human prions in a sample and transgenic mice used for same"

United States Patent 6,008,435. Issued December 28, 1999

Prusiner, Stanley B.; Michael R. Scott; Glenn C. Telling "Method of detecting prions in a sample and transgenic animal used for same"

United States Patent 5,763,740. Issued June 9, 1998
United States Patent 5,908,969. Issued June 1, 1999

Prusiner, Stanley B.; Michael R. Scott; Glenn C. Telling "Detecting prions in a sample and prion preparation and transgenic animal used for same"

United States Patent 5,792,901. Issued August 11, 1998.

Papers submitted or in preparation

--------------------------------------- -------------------------------------------- --------------------------------------------- ------------------------------------------- -------------------.
--------------------------------------------- --------------------------------------------- --------------------------------------------- -------------------------------------------- ---------------------- .
--------------------------------------------- -------------------------------------------- --------------------------------------------- --------------------------------------------- -----------------------------.

Papers published or in press

--------------------------------------------- ----------------------------------------------- ---------------------------------------------- ---------------------------------------------- ---------------------------------------------- -------------------------------------------- ----------------------------------------------- --------
Telling, G.C. Editorial: Prion-related disorders. Biochimica et Biophysica Acta, 1772(6): 597, 2007
Kurt , Timothy D., Matthew R. Perrott, Carol J. Wilusz, Jeffrey Wilusz, Surachai Supattapone, Glenn C. Telling, Mark D. Zabel and Edward A. Hoover . Efficient In Vitro Amplification of Chronic Wasting Disease PrP^res. J. Virol. 81(17):9605-8, 2007
Nazor, Karah E ., Tanya Seward and Glenn C. Telling Novel behavioral motor and neuropathological deficits in mice deficient for prion protein. Biochimica et Biophysica Acta, 1772(6): 645-653, 2007
Candace K. Mathiason, Jenny G. Powers, Sallie J. Dahmes, David A. Osborn, Karl V. Miller, Robert J. Warren, Gary L. Mason, Sheila A. Hays, Jeanette Hayes-Klug, Davis M. Seelig, Margaret A. Wild, Lisa L. Wolfe, Terry R. Spraker, Michael W. Miller, Christina J. Sigurdson, Glenn C. Telling, and Edward A. Hoover. Infectious Prions in the Saliva and Blood of Deer with Chronic Wasting Disease. Science, 314: 133-6, 2006.
Angers, Rachel C., Shawn R. Browning, Tanya S. Seward, Christina J. Sigurdson, Michael W. Miller, Edward A. Hoover and Glenn C. Telling. Prions in Skeletal Muscles of Deer with Chronic Wasting Disease. Science, 311: 1117, 2006.Featured article in Science Express
Bian, Jifeng , Karah E. Nazor, Rachel Angers, Michael Jernigan, Tanya Seward, Adrian Centers, Michael Green and Glenn C. Telling. GFP-tagged PrP supports compromised prion replication in transgenic mice. Biochem. Biophys. Res. Comm, 340: 894-900, 2006
Telling, Glenn C. Study of prion types questions classification system. The Lancet Neurology , 4: 1-2, 2005
Telling, Glenn C. Anchors away: Of plaques and pathology in prion disease. N. Engl. J Med., 353(11): 1177-1179, 2005.
Nazor, Karah E ., Franziska Kuhn, Tanya Seward, Mike Green, Daniel Zwald, Mario Pürro, Jaqueline Schmid, Karin Biffiger, Aisling M. Power, Bruno Oesch, Alex J. Raeber and Glenn C. Telling. Immunodetection of disease-associated mutant PrP which accelerates disease in GSS transgenic mice. EMBO Journal , 24(13): 2472-2480, 2005.
Browning, Shawn R., Gary L. Mason, Tanya Seward, Mike Green, Gwyneth A. J.Eliason, Candace Mathiason, Christina Sigurdson, Michael W. Miller, Elizabeth S. Williams, Ed Hoover and Glenn C. Telling. Transmission of prions from mule deer and elk with chronic wasting disease to transgenic mice expressing cervid PrP. J. Virol. 78(23) : 13345-13350, 2004
Moroncini G, Kanu N, Solforosi L, Abalos G, Telling GC, Head M, Ironside J, Brockes JP, Burton DR, Williamson RA. Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrP^Sc. Proc. Natl. Acad. Sci. USA , 101(28): 10404-10409, 2004
Yadavalli, Rajgopal , Rodney P. Guttmann, Tanya Seward, Adrian P. Centers, R. Anthony Williamson and Glenn C. Telling. Calpain-dependent endoproteolytic cleavage of PrP^Sc modulates PrP^Sc accumulation and prion propagation in scrapie infected cells. J. Biol. Chem., 279(21):21948-56, 2004
Telling, Glenn C. The mechanism of prion strain propagation. Genome Biology, 5(5):222.1-222.3, 2004
Korth, C ., Kiyotoshi Kaneko, Darlene Groth, Norbert Heye, Glenn Telling, James Mastrianni, Piero Parchi, Pierluigi Gambetti, Robert Will, James Ironside, Cornelia Heinrich, Patrick Tremblay, Stephen J. DeArmond and Stanley B.Prusiner. Abbreviated incubation times for human prions in mice expressing a novel chimeric prion protein transgene. Proc. Natl. Acad. Sci. USA , 100 (8): 4784-4789, 2003
Connolly, John G., Roth J. Tate, Glenn C. Telling, Jan Fraser, Debbie Brown and Mark W. Head. Properties of the cellular prion protein expressed in Xenopus oocytes. Neuroreport, 13 (9): 1229-1233, 2002
Bosque, Patrick J., Chongsuk Ryou, Glenn Telling, David Peretz, Giuseppe Legname, Stephen J. DeArmond and Stanley B. Prusiner. Prions in skeletal muscle. Proc. Natl. Acad. Sci. USA , 99: 3812-3817, 2002
Mastrianni, J. A., S. Capellari, G. C. Telling, D. Han, P. Bosque, S. B. Prusiner, and S. J. DeArmond . Inherited prion disease caused by the V210I mutation: Transmission to transgenic mice. Neurology, 57: 2198-2205, 2001.
Telling, Glenn C. Protein-based PCR for prion diseases? Nature Medicine, 7(6): 11-12, 2001
Telling, Glenn C. Transgenic studies of prion diseases. Methods in Molecular Medicine, 58: 111-128, 2001 (Invited Review)
Campbell, Susan, Ulla Dennehy and Glenn Telling. Analyzing the influence of PrP primary structure on prion pathogenesis in transgenic mice. Archives of Virology[Suppl], 16 : 87-94, 2000
Telling, G.C. , Prion protein genes and prion diseases: studies in transgenic mice. Neuropath. Appl. Neurobiol, 26: 209-220, 2000
Mastrianni, James A., Randal Nixon, Robert Layzer, Glenn C. Telling, Dong Han, Stephen J. DeArmond, Stanley B. Prusiner. Prion protein conformation in a patient with sporadic fatal insomnia. N. Engl. J. Med., 340:1630-1638, 1999
Telling, Glenn C. Prion diseases . Horizons in Medicine, 10: 415-428,1999
Fisher, Elizabeth, Glenn Telling and John Collinge. Prions and the prion disorders. Mammalian Genome, 9, 497-502, 1998
Westaway, David, Glenn Telling, and Suzette Priola. Prions. Proc. Natl. Acad. Sci. USA ., 95: 11030-11031, 1998
Scott, Michael R ., Jiri Safar, Glenn Telling, Oanh Nguyen, Darlene Groth, Marilyn Torchia, Ruth Koehler, Patrick Tremblay, Dirk Walther, Fred E. Cohen, Stephen J. DeArmond, and Stanley B. Prusiner. Identification of a prion protein epitope modulating transmission of BSE prions to transgenic mice. Proc. Natl. Acad. Sci. USA ., 94: 14279-14284, 1997
Telling, Glenn C ., Patrick Tremblay, Marilyn Torchia, Stephen J. DeArmond, Fred E. Cohen and Stanley B. Prusiner. N-terminally tagged prion protein supports prion propagation in transgenic mice. Protein Science, 6: 825-833, 1997
Muramoto, Tamaki, Stephen J. DeArmond, Michael Scott, Glenn C. Telling, Fred E. Cohen and Stanley B. Prusiner. Heritable neuronal storage disease in mice expressing prion protein with deletion of an α-helix. Nature Medicine, 3: 750-755, 1997
Bamborough, P ., H. Wille, G. C. Telling, F. Yehiely, S. B. Prusiner and F. E. Cohen. Prion protein structure and scrapie replication: theoretical, spectroscopic and genetic investigations. Cold Spring Harbor Laboratory Symposium, 61, 495-509, 1997
Telling, Glenn C ., Piero Parchi, Stephen J. DeArmond, Pietro Cortelli, Pasquale Montagna, Ruth Gabizon, James Mastrianni, Elio Lugaresi, Pierluigi Gambetti and Stanley B. Prusiner. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science, 274: 2079-2082, 1996
Telling, Glenn C ., Takeshi Haga, Marilyn Torchia, Patrick Tremblay, Stephen J. DeArmond and Stanley B. Prusiner. Interactions between wild type and mutant prion proteins modulate neurodegeneration in transgenic mice. Genes and Development, 10:1736-1750, 1996
Gabizon, Ruth, Glenn Telling, Zeev Meiner, Michele Halimi, Irit Kahana and Stanley B. Prusiner. Different properties of mutant and wild-type PrP proteins in heterozygous patients with Creutzfeldt-Jakob disease. Nature Medicine, 2: 59-64, 1996
Telling, G ., M. Scott and S. B. Prusiner: Transgenetics and Gene Targeting in Studies of Prion Diseases. Frontiers in Endocrinology, 16, 237-266, 1996
Prusiner, S.B ., G. Telling, F. E. Cohen and S. J. DeArmond. Prion Diseases of Humans and Animals. Seminars in Virology, 7: 159-173, 1996
Scott, M. R. D ., G. C. Telling and S. B. Prusiner: Transgenetics and gene targeting in studies of prion diseases. Current Topics in Microbiology and Immunology, 207, 95-123, 1996
Telling, Glenn C ., Michael Scott, James Mastrianni, Ruth Gabizon, Marilyn Torchia, Fred E. Cohen, Stephen J. DeArmond and Stanley B. Prusiner. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell, 83: 79-80, 1995
Williams, J ., M. Williams, C. Liu and G. Telling: Assessing the role of E1A in the differential oncogenicity of Group A and Group C Human Adenoviruses. Current Topics in Microbiology and Immunology, 199, 149-175, 1995
Telling, Glenn C ., Michael Scott, Karen K. Hsiao, Dallas Foster, Shu-Lian Yang, Marilyn Torchia, Katie C. L. Sidle, John Collinge, Steven J. DeArmond and Stanley B. Prusiner. Transmission of Creutzfeldt-Jakob Disease from Humans to Transgenic Mice Expressing Chimeric Human-Mouse Prion Protein. Proc. Natl. Acad. Sci.USA ., 91: 9936-9940, 1994
Carlson, G.A ., C. Ebeling, S-L. Yang, G. Telling, M. Torchia, D. Groth, D. Westaway, S. J. DeArmond and S. B. Prusiner. Prion isolate specified allotypic interactions between the cellular and scrapie prion proteins in congenic and transgenic mice. Proc. Natl. Acad. Sci. USA ., 91: 5690-5694, 1994
Telling, G. C. and J. Williams. Constructing chimeric type 12/type 5 adenovirus E1A genes and using them to identify an oncogenic determinant of adenovirus type 12. Journal of Virology, 68: 877-887, 1994
Telling, G. C ., S. Periera, M. Szatkowski-Ozers and J. Williams. Absence of an essential regulatory influence of the adenovirus E1B 19-kilodalton protein on viral growth and early gene expression in human diploid WI38, HeLa and A549 cells. Journal of Virology, 68: 541-547, 1994
Borchelt, D. R ., M. Rogers, N. Stahl, G. Telling and S. B. Prusiner. Release of the cellular prion protein from cultured cells after loss of its glycoinositol anchor. Glycobiology, 3: 319-329, 1993
Telling, G. C. and J. F. Williams. The E1B 19kDa protein is not essential for transformation of rodent cells in vitro by adenovirus type 5. Journal of Virology, 67: 1600-1611, 1993
Hayes, B. W ., G. C. Telling, M. M. Myat, J. F. Williams and S. J. Flint. The adenovirus L4 100 kilodalton protein is necessary for efficient translation of viral late mRNA species. Journal of Virology, 64: 2732-2742, 1990

Book Chapters

---------------------------------- --------------------------------------- ------------------------------------ ---- --------------------------------------- -----------
---------------------------------------- --------------------------------------- --------------------------------------- --------------------------------------- ----------------------
Nazor, Karah E. and Glenn C. Telling. Transgenetic models of prion replication. In: Handbook of Laboratory Animal Science, Second Edition, Animal Models Volume III Jann Hau (Ed.) CRC Press London, pp. 113 - 127, 2004
Nazor, Karah E . and Glenn C. Telling. Transgenic Mouse Models of Prion Diseases. In: Prions and Prion Diseases: Current PerspectivesGlenn C. Telling (Ed.) Horizon Scientific Press, UK, pp. 121-144, 2004
Prusiner SB, Baron H, Carlson G, Cohen FE, DeArmond SJ, Gabizon R, Gambetti P, Hope J, Kitamoto T, Laplanche J-L, Tateishi J, Telling G, Weissmann C and Will R. Report on Prions. In: Virus Taxonomy: The Classification and Nomenclature of Viruses. The Seventh Report of the International Committee on Taxonomy of Viruses M.H.V. van Regenmortel, C.M. Fauquet, D.H.L. Bishop, E.B. Carstens, M.K.Estes, S.M. Lemon, J. Maniloff, M.A. Mayo, D.J. McGeoch, C.R. Pringle, R.B. Wickner (Eds). Academic Press, San Diego California, pp 1032-1039, 2000
Telling, Glenn C. Prion diseases of Humans and Animals. In: Viral Ecology, Christon J. Hurst (Ed.) Academic Press, pp. 593-619, 2000
Telling, Glenn C. and John Collinge. Transmissible spongiform encephalopathies of Humans and Animals. In: Infectious diseases, Donald Armstrong and Jonathan Cohen (Eds.) Mosby International, Volume 1, Section 2, pp 19.1-19.6, 1999
Telling, Glenn C. Prions. In: Everything you need to know about old age psychiatry…, Robert Howard (Ed.) Wrightson Biomedical Publishing Ltd, pp. 73-89, 1999
Gabizon, Ruth, Glenn Telling, Zeev Meiner, Michele Halimi, Irit Kahana and Stanley B. Prusiner. Properties of the prion proteins in Creutzfeldt-Jakob disease patients heterozygous for the E200K mutation. In: Prions and Brain Diseases in Animals and Humans. Morrison, D. R. O. (Ed) Plenum Press, New York, New York, pp. 225-243,1998
Prusiner, S. B ., Kaneko, K ., Vey, M ., Telling, G ., Scott, M ., Gabizon, R ., Taraboulos, A ., DeArmond, S. J., Cohen, F. E.: Molecular biology of prion propagation. In: Prions and Brain Diseases in Animals and Humans . Morrison, D. R. O. (Ed) Plenum Press, New York, New York, pp. 305-306 , 1998
Telling, Glenn C ., Michael Scott and S. B. Prusiner: Deciphering prion diseases with Transgenic Mice. In: Bovine Spongiform Encephalopathy: The BSE Dilemma. Clarence J. Gibbs Jr. (Ed.) Springer Verlag, New York, pp. 202-231, 1996
Gabizon, Ruth, Glenn Telling, Zeev Meiner, Michele Halimi, Irit Kahana and Stanley B. Prusiner. Altered properties of prion proteins in Creutzfeldt-Jakob disease patients heterozygous for the E200K mutation. In: Transmissible Subacute Spongiform Encephalopathies: Prion Diseases. L. Court and E. Dodet (Ed) Elsevier, Paris, pp. 199-205, 1996

Other publications

Telling, Glenn C. Bovine Spongiform Encephalopathy. Encyclopedia Americana, Grolier Inc ., Danbury, Connecticut, 2003

Abstract

Telling, Glenn C. Modeling prion transmission barriers using transgenic and in vitro approaches". NeuroPrion CWD Workshop, Edinburgh, UK, September 2007
Angers, R.C., S.R. Browning, T.S. Seward, M.W. Miller, A. Balachandran, D. McKenzie, E.A. Hoover, G.C. Telling. C haracterization of CWD prion strains using transgenic mice. Prion 2007 : Edinburgh, UK, September 2007
Green, K.M., J. Castilla, T.S. Seward, C. Soto, G.C. Telling . Accelerated studies of interspecies prion transmission using combined transgenic and PMCA technologies. Prion 2007 : Edinburgh, UK, September 2007 (Platform presentation for K. Green)
Nunn, Michael, Kenneth Tyler, Glenn Telling, Christine Zink, and Eugene Major. Emerging and Re-emerging viral infections of the human nervous system: What we know from the past and what we need to know for the future. 40th Winter Conference on Brain Research, Snowmass, CO, January 2007
K.M. Green, S.R. Browning, T.S. Seward, M. Green, E.A. Hoover, G.C. Telling. Interspecies prion transmission is controlled by conformational compatibility of PrP^Sc and heterotypic PrP^C. PRION2006- Strategies, advances and trends towards protection of society, Turin, Italy, October 2006 (Platform presentation for K. Green)
R.C. Angers, S.R. Browning, T.S. Seward, C.J. Sigurdson, M.W. Miller, E.A. Hoover, G.C. Telling. Prions in Skeletal Muscle of CWD Infected Deer . PRION2006- Strategies, advances and trends towards protection of society, Turin, Italy, October 2006
Telling, Glenn C., Kristi Green and Rachel Angers. Deciphering mechanisms of prion transmission using transgenic mice . 10th International Symposium for Zoonosis Control - Protection of Society from Infectious Threat , Sapporo, Japan, August 2006
Browning, Shawn R., Kristi Green, Tanya Seward, and Glenn C. Telling. Transgenic mouse models of chronic wasting disease. IBC's Second Annual Transmissible Spongiform Encephalopathies (TSEs) meeting - Science and strategies to detect and control infectivity in biopharmaceuticals and blood products, Reston, VA, November 2005
Telling, Glenn C., Transmission of prions from mule deer and elk with chronic wasting disease to transgenic mice expressing cervid PrP. National Institute of Toxicological Research International Symposium, Seoul, Korea, October 2005
Telling, Glenn C. Transgenic mouse models of animal and human prion diseases - insights into the mechanisms of prion replication, species barriers and prion strains. Proceedings of the International Symposium on Advanced Virology, Beijing, China, October 2005
Telling, Glenn C. , Shawn R. Browning, Kristi Green, Rachel Angers, Gary L. Mason, Tanya Seward, Mike Green, Gwyneth A. J. Eliason, Candace Mathiason and Ed Hoover. Transgenetic studies of chronic wasting disease - an overview. International Conference: "Prion 2005 - Between fundamentals and society's needs" Düsseldorf, Germany, October, 2005
Telling, Glenn C. Overview on progress in detecting and quantifying prion infectivity by bioassay in transgenic mice. World Health Organization (WHO) Consultation on Tissue Infectivity Distribution in Transmissible Spongiform Encephalopathies, WHO Headquarters, Geneva, September 2005
Browning, Shawn R., Kristi Green, Gary L. Mason, Tanya Seward, Mike Green, Gwyneth A. J. Eliason, Candace Mathiason, Ed Hoover and Glenn C. Telling. Transgenic mouse models for studying chronic wasting disease. Second International Chronic Wasting Disease Symposium, Madison, Wisconsin, July 2005
Telling, Glenn C., Shawn Browning and Karah E. Nazor. Transgenic models of prion replication. 2nd International Symposium "The New Prion Biology: Basic Science, Diagnosis and Therapy", Venice, Italy, April 2005
Nazor, Karah E ., Franziska Kuhn, Tanya Seward, Mike Green, Daniel Zwald, Mario Pürro, Jaqueline Schmid, Karin Biffiger, Bruno Oesch, Alex J. Raeber and Glenn C. Telling. Transgenic studies of Gerstmann-Sträussler-Scheinker prion pathogenesis. Molecular Mechanisms of Transmissible Spongiform Encephalopathies (Prion Diseases), Snowbird, Utah, January, 2005
Peretz, David , Melissa Michelitsch, Carol Gao, Xuemei Wang, Alex Gyenes, Robert Shimizu, John Hall, Xue Wu, Glenn C. Telling, Bruce Phelps, David Chien and Celine Hu. Studies on Detecting Infectious Prions (PrP^Sc) Spiked in Human Blood Products. Molecular Mechanisms of Transmissible Spongiform Encephalopathies (Prion Diseases), Snowbird, Utah, January, 2005
Browning, Shawn R., Karah Nazor, Tanya Seward and Glenn C. Telling. Transgenic models of prion replication. 44th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington , DC , October 30 - November 2, 2004
Browning, Shawn R., Gary L. Mason, Tanya Seward, Mike Green, Gwyneth A. J. Eliason, Candace Mathiason, Ed Hoover and Glenn C. Telling. Transgenic model for chronic wasting disease. Animal Prion diseases and the Americas, Ames, Iowa, October 2004
Nazor, Karah E ., Franziska Kuhn, Tanya Seward, Mike Green, Daniel Zwald, Mario Pürro, Jaqueline Schmid, Karin Biffiger, Bruno Oesch, Alex J. Raeber and Glenn C. Telling. Transgenic studies of Gerstmann-Sträussler-Scheinker prion pathogenesis. Animal Prion diseases and the Americas, Ames, Iowa, October 2004
Connolly, John G., Roth J. Tate, Glenn C. Telling, Jan Fraser, Debbie Brown, Neil McLennan and Mark W. Head. Cellular prion protein expressed in Xenopus oocytes. The Scottish Neuroscience Group, University of Strathclyde, 2004.
Telling, Glenn C. Transgenic approaches for studying Chronic Wasting disease, Center for Food and Nutrition Policy Forum: Transmissible Spongiform Encephalopathies in Animal and Human Health: The Science and the Policy, Virginia Tech, March 2004
Moronconi, G, N. Kanu, L. Solforosi, G. Albaso, G. Telling, J.P. Brokes, R. A. Williamson. Motif-grafted antibodies containing the replicative interface of PrP are specific for PrP^Sc. International Prion Conference: From Basic Research to Intervention Concepts, München - Germany, October 2003
Yadavalli, Rajgopal , Rodney P. Guttmann, Adrian P. Centers, Tanya Seward, R. Anthony Williamson and Glenn C. Telling. Prion propagation is a calpain-dependent process. International Prion Conference: From Basic Research to Intervention Concepts, München - Germany, October 2003
Telling, Glenn C. An Update on chronic wasting disease and other prion diseases. Food Research Institute Annual Meeting, Madison WI, May 2003
Centers, Adrian, Michael Jernigan and Glenn Telling. Hybrid green fluorescent-prion proteins for monitoring PrP^Sc production and localization in prion infected cells. TSE diseases, Keystone Symposium, Brekenridge, CO, April 2003
Telling, Glenn . Prion Diseases - Overview of General Concepts. Chronic Wasting Disease Symposium, Denver, CO, August 2002
Browning, Shawn, Tanya Riddle and Glenn Telling. Production and Preliminary Characterization of Transgenic Mice for studying Chronic Wasting Disease. Chronic Wasting Disease Symposium, Denver, CO, August 2002
Browning, Shawn, Tanya Riddle and Glenn Telling. Transgenic studies of Chronic Wasting Disease, a prion disease of Cervids. American Society for Virology 21st Annual Meeting, University of Kentucky, Lexington, KY, July 2002
Nazor, Karah E ., Aisling Power, Tanya Riddle, and Glenn Telling. Transgenic and in vitro studies of GSS prion pathogenesis and propagation. American Society for Virology 21st Annual Meeting, University of Kentucky, Lexington, KY, July 2002
Telling, Glenn and Adrian Centers. Hybrid green fluorescent-prion proteins for monitoring PrP^Sc production and localization in prion infected cells. American Society for Virology 21st Annual Meeting, University of Kentucky, Lexington, KY, July 2002
Telling, Glenn and Adrian Centers. Hybrid green fluorescent-prion proteins for monitoring PrP^Sc production and localization in prion infected cells. American Federation for Aging Research 15th Annual Grantee Conference, New York, NY, April 2002
Connolly, John G ., Roth J. Tate, Glenn C. Telling, Jan Fraser, Debbie Brown and Mark W. Head Properties of the cellular prion protein expressed in Xenopus oocytes. Biochemical Society Meeting, Herriot-Watt University, Edinburgh, April 2002
Connolly, J.G ., R.J. Tate, G.C. Telling , and. M.W. Head. Non-isotopic detection of cellular prion protein expressed in Xenopus oocytes . Society Neurosciences Meeting, San Diego, November 2001
Telling, Glenn C. Studying human prion diseases in transgenic mice. First Conference of the Creutzfeldt-Jakob Disease Foundation, Inc ., Miami, Florida, May 2000
Telling, Glenn C. Perspectives on the use of transgenic mice. Biotechnology and Biological Sciences Research Council (BBSRC) Biology of Spongiform Encephalopathies (BSEP) Workshop , Keele University, UK, April 2000
Dennehy, Ulla, Susan Campbell and Glenn C. Telling . Transgenic studies of prion transmission barriers. International symposium on the characterization and diagnosis of prion diseases in animals and man, Tubingen, Germany, T8, p17, 1999
Telling, Glenn C . Prion strains and species barriers: Investigating Creutzfeldt Jakob disease, BSE and other prion diseases in transgenic mice. 13th International Conference on Lymphoid Tissues in Immune Reactions, Geneva, Switzerland, August 1999
Telling, Glenn C. Bovine Spongiform Encephalopathy in the United Kingdom and the relationship with the new variant of Creutzfeldt-Jakob Disease in humans: An Update. XVIII Summer Course at Universidad del Pais Vasco/Euskal Herriko Unibersitatea, San Sebastian, Spain, July 1999
Telling, Glenn C. Transgenic mouse models of prion disease. Neurobiology of Aging, 19 [Suppl.]: 885, 1998
Telling, Glenn C . Insights into the mechanisms of prion propagation from Transgenic mouse studies. Second IIR Ltd Sponsored Symposium: "Successfully Managing The TSE Crisis", London, June 1998
Telling, Glenn C . Transmissible spongiform encephalopathies: Prions. Institute of Animal Technology, Institute of Psychiatry, Kings College London, May 1998
Telling, Glenn C. Transgenic mice and prion diseases: Sensitive bioassays and insights into mechanisms of prion propagation. "Successfully Managing The TSE Crisis", IIR Ltd. Symposium, London, March 1998
Telling, Glenn C. Prion strains and species barriers: studies with transgenic mice. BBSRC Biology of Spongiform Encephalopathies Workshop, University of Warwick, March 1998
Bosque, P., G. Telling, J. Cayetano, S. DeArmond and S. Prusiner. Evidence for prion replication in skeletal muscle. Ann. Neurol. 42: 986, 1997
Prusiner, S. B., Kaneko, K., Vey, M., Telling, G ., Scott, M., Gabizon, R., Taraboulos, A., DeArmond, S. J., Cohen, F. E.: Molecular biology of prion propagation. International Seminar on Nuclear War and Planetary Emergencies, 21st Session (Zichichi, A., Ed.), pp. 49-50, 1997
Meiner, Z., A. Yanai, G. Telling , M. Chalimi, A. Tarabolous, S. B. Prusiner and R. Gabizon: Prion protein with the E200K mutation exhibits properties similar to the cellular isoform. Neurology [Suppl.], 48: A295, 1997
Prusiner, S. B., K. Kaneko, M. Vey, G. Telling, M. Scott, R. Gabizon, A. Tarabolous, S. J. DeArmond and F. E. Cohen: Molecular biology of prion propagation. Abstracts of papers presented at the NATO Advanced Research Workshop: Prions and Brain Diseases in Animals and Humans, Erice, Italy, 19-22, p. 22, 1996
Gabizon, Ruth, Glenn Telling , Zeev Meiner, Michele Halimi, Irit Kahana and Stanley B. Prusiner. Altered properties of prion proteins in Creutzfeldt-Jakob disease patients heterozygous for the E200K mutation. 3rd International Symposium on Transmissible Subacute Spongiform Encephalopathies: Prion Diseases, Paris, France, 18-20 March 1996
Prusiner, Stanley B., Martin Vey and Glenn C. Telling: Prion formation and Chaperones. 10th International Congress of Virology, Jerusalem, Israel, 1996
Telling, Glenn C ., Patrick Tremblay, Marilyn Torchia, Stephen J. DeArmond, Fred E. Cohen and Stanley B. Prusiner: N-terminally tagged prion protein supports prion propagation in transgenic mice. Mol. Biol.Cell, 7 [Suppl.]: 651a, 1996
Prusiner, S. B., K. Kaneko, M. Vey, G. Telling , M. Scott, S. J. DeArmond and F. E. Cohen: Prion propagation and formation of the scrapie prion protein isoform. Abstracts of papers presented at the LXI Cold Spring Harbor Symposium on Quantitative Biology: Function and Dysfunction in the Nervous System, p. 3, 1996
Heye, N., G. C. Telling and S. B. Prusiner: Prion propagation in transgenic mice expressing human and chimeric human-mouse PrP transgenes. German Neurology Congress, Göttingen, Germany, September 25-28, 1996
Bosque, P., G. Telling , D. Westaway, J. Cayetano, S. DeArmond and S. Prusiner. Prion protein over-expression exclusively in skeletal muscle causes spontaneous myopathy. Neurology [Suppl.], 46: 250, 1996
Telling, Glenn . C., James A. Mastrianni, Stephen J. DeArmond and Stanley B. Prusiner. Exploring the mechanisms of prion propagation using mice expressing human and chimeric mouse/human prion protein transgenes. Neurology [Suppl.] , 46 : 488, 1996
Prusiner, S. B., K. -M. Pan, M. A. Baldwin, G. C. Telling and M. Scott: Transgenetic investigations of prion diseases. International Symposium on Prion Diseases, Göttingen, Germany, October 26-27, 1995
Prusiner, S. B ., K. -M. Pan, M. A. Baldwin, G. C. Telling and M. Scott: The prion diseases. AIDS Res.Hum. Retroviruses [Suppl. 1], 11: S71, 1995
Prusiner, S. B., G. Telling , D. Groth, M. Scott and S. J. DeArmond. Transgenetics of prion diseases. Front. Endocrinol ., 16: 237, 1995
Telling, G . and S. B. Prusiner. Transgenic mouse models of human prion diseases. 6th International Workshop on Bovine Spongiform Encephalopathy, Williamsburgh VA, 1995
Bosque, P., G. Telling , D. Hanahan and S. B. Prusiner. Ectopic expression of the prion protein directed by the insulin gene promoter to the pancreas of transgenic mice. Neurology [Suppl.], 45: 308, 1995
Telling, G. C ., D. Foster, S.-L. Yang, S. J. DeArmond and S. B. Prusiner. Transgenic mice expressing human and chimeric human-mouse prion proteins carrying the codon 102 mutation of GSS. Neurology [Suppl.], 45: 308, 1995
Prusiner, S. B., G. Telling , D. Groth, M. Scott and S. J. DeArmond. Transgenetics of prion diseases. International Symposium on: "Where genotype does not match phenotype", Volterra, Italy, 1994
Telling, G. C., M. Scott, H. Schätzl, D. Foster, S.-L. Yang, M. Torchia, F. E. Cohen, S. J. DeArmond and S. B. Prusiner. Prion transmission from humans to transgenic mice expressing chimeric human-mouse prion protein (PrP) provides evidence or a species-specific factor in prion propagation. Mol. Biol. Cell [Suppl.], 5: 473a, 1994
Carlson, G.A., C. Ebeling, S-L. Yang, G. Telling , M. Torchia, D. Groth, D. Westaway, S. J. DeArmond and S. B. Prusiner. The prion protein gene, a novel genetic locus and prion-specified information control regional patterns of PrP^Sc accumulation and neuropathology in mice. Neurobiology of Aging [Suppl. 1] , 15: 157, 1994
Telling, G. C . and S. B. Prusiner. Altered patterns of expression of mutant forms of human PrP in neuroblastoma cells. Ninth International Congress of Virology, Glasgow UK, 1993
Telling, G., C. Liu and J. Williams. Constructing chimeric E1A genes and using them to locate an oncogenic determinant of type 12 adenovirus. Imperial Cancer Research Fund DNA Tumour Virus Symposium, Cambridge UK, 1993
Telling, G. C ., S. Periera and J. Williams. A dubious oncogene; evidence that the product of the type 5 adenovirus E1B 19K gene is not required for transformation of rodent cells. Imperial Cancer Research Fund DNA Tumour Virus Symposium, Cambridge UK, 1999
Hayes, B. W., G. C. Telling , J. F. Williams and S. J. Flint. An adenovirus 5 late non-structural protein regulates the efficiency of viral late mRNA translation. Cold Spring Harbor Laboratory Translational Control Symposium, Cold Spring Harbor Laboratory NY, 1990

Books

Prions and Prion Diseases: Current Perspectives. Glenn C. Telling (Ed.) Horizon Scientific Press, Wymondham UK, 2004

D. Invited symposia and workshops

Feb 2008	Second annual PrP^CANADA meeting: "Making Tracks" Toronto, Canada,
Sept 2007	NeuroPrion2007 - Chronic Wasting Disease Workshop, Edinburgh UK"Transgenic mouse models of chronic wasting disease"
May 2007	107^th General Meeting of the American Society for Microbiology, Toronto, Canada"Transgenic Mouse Models of Chronic Wasting Disease"
July 2007	144th AVMA Annual Convention, Washington DC"Transgenic Mouse Models for Chronic Wasting Disease research "
Jan 2007	Emerging and Re-emerging viral infections in the human nervous system, Winter Conference on Brain Research, Snowmass, CO "Emerging and Re-emerging viral infections of the human nervous system: What we know from the past and what we need to know for the future"
Aug 2006	10th International Symposium for Zoonosis Control - Protection of Society from infectious Threat , Sapporo, Japan "Deciphering mechanisms of prion transmission using transgenic mice"
Aug 2006	Ninty-sixth Association of American Feed Control Official's (AAFCO) annual meeting, TSE Issues committee meeting, Oklahoma City, OK "Transgenic mouse models of prion diseases"
April 2006	Mini-Symposium on Prion Diseases, National Animal Disease Center, Ames, IA "Transgenic mouse models of chronic wasting disease and other prion disorders"
Feb 2006	Alberta Prion Research Symposium, Alberta Prion Research Institute, Calgary Canada" Transgenic mouse models of chronic wasting disease"
Nov 2005	IBC's Second Annual Transmissible Spongiform Encephalopathies (TSEs) meeting - Science and Strategies to Detect and Control Infectivity in Biopharmaceuticals and Blood Products, Reston, VA " Transgenic mouse models of chronic wasting disease"
Nov 2005	Prion Biology: Puzzles and Paradoxes, The Banbury Center, Cold Spring Harbor, New York "Transgenic studies of CWD and mechanisms controlling prion transmission barriers"
Oct 2005	International Symposium on Advanced Virology, Beijing, China, "Transgenic mouse models of human and animal prion diseases" (Keynote Address)
Oct 2005	International Conference: "Prion 2005 - Between fundamentals and society's needs" Düsseldorf, Germany, "Transgenetic studies of chronic wasting disease"
Oct 2005	National Institute of Toxicological Research International Symposium, Seoul , Korea , " Transgenic mouse models of chronic wasting disease "
Oct 2005	Mad Cow and related TSE diseases: Science, Risks and Public Policy, University of Connecticut, " Recent breakthroughs in chronic wasting disease research"
Sept 2005	World Health Organization (WHO) Consultation on Tissue Infectivity Distribution in Transmissible Spongiform Encephalopathies, WHO Headquarters, Geneva, "Progress in detection and quantification of prion infectivity by bioassay in transgenic mice "
July 2005	Second International Chronic Wasting Disease Symposium, Madison, Wisconsin, "Studying CWD biology with transgenic mice" (Organizer and Chair)
April 2005	Second International Symposium "The New Prion Biology: Basic Science, Diagnosis and Therapy", Venice, Italy, "Transgenic models of prion replication"
Oct 2004	CWD/TSE Symposium, North Dakota State Board of Animal Health, Bismarck, ND, "Recent breakthroughs in CWD research"
Oct 2004	Animal Prion Diseases in the Americas, Ames, IA, " Transgenetic studies of chronic wasting disease"
Oct 2004	Forty-fourth Interscience Conference on Antimicrobial Agents and Chemotherapy Prion Disease Symposium, Washington DC, "Transgenic models of prion replication"
March 2004	Center for Food and Nutrition Policy Forum: Transmissible Spongiform Encephalopathies in Animal and Human Health: The Science and the Policy, Virginia Tech, "Transgenic approaches for studying chronic wasting disease"
Oct 2003	International Prion Conference: From Basic Research to Intervention Concepts, München - Germany, " Prion propagation is a calpain-dependent process"
May 2003	Food Research Institute Annual Meeting, Madison WI, "An update on chronic wasting disease and other Prion diseases"
Aug 2002	Chronic wasting disease symposium, Denver, CO, "Prion Diseases - Overview of General Concepts"
Aug 2002	Chronic wasting disease symposium, Denver, CO, "Production and Preliminary Characterization of Transgenic Mice for studying chronic wasting disease"
Feb 2002	NIH-sponsored TSE workshop, Bethesda, MD
Oct 2001	Interdisciplinary Conference on State Law and Public Health, Lexington, KY, "Policy Issues in Bovine Spongiform Encephalopathy and other food borne diseases"
June 2001	Symposium on the neuropathology of neurodegenerative diseases, Indiana University, "New transgenic and in vitro approaches for studying prion diseases "
May 2000	First Conference of the Creutzfeldt-Jakob disease Foundation, Inc., Miami, Florida, " Studying human prion diseases in transgenic mice"
April 2000	Biotechnology and Biological Sciences Research Council (BBSRC) Biology of Spongiform Encephalopathies (BSEP) Workshop , Keele, UK, "Perspectives on the use of transgenic mice" *(Organizer and Chair)*
Sept 1999	International Symposium on the characterization and diagnosis of prion diseases in animals and man, Tubingen, Germany, " Transgenic studies of prion transmission barriers"*(Chair)*
Aug 1999	Thirteenth International Conference on Lymphoid Tissues in Immune Reactions, Geneva, Switzerland, "Prion strains and species barriers: Investigating Creutzfeldt Jakob disease, BSE and other prion diseases in transgenic mice"
July 1999	Eighteenth summer course at Universidad del Pais Vasco/Euskal Herriko Unibersitatea, San Sebastian, Spain, "Bovine Spongiform Encephalopathy in the United Kingdom and the relationship with the new variant of Creutzfeldt-Jakob disease in humans: An update"
June 1999	National Academy of Sciences (NAS) and the German American Academic Council's 5th Annual German-American Frontiers of Science Symposium: Potsdam, Germany, *(Organizer)*
Nov 1998	Critical data and scientific uncertainties: The statistics of transmissible spongiform encephalopathies (TSE's), Isaac Newton Institute for Mathematical Sciences, University of Cambridge,
June 1998	National Academy of Sciences (NAS) and the German American Academic Council's 4th Annual German-American Frontiers of Science Symposium, Irvine, California, *(Organizer)*
Sept 1998	Institute of Psychiatry Short Course in Old Age Psychiatry, Institute of Psychiatry, Kings College, London, "Transmissible Dementias"
July 1998	Sixth International Conference on Alzheimer's Disease and Related Disorders, Amsterdam, The Netherlands, "Transgenic Mouse Models of Prion Diseases"
June 1998	‘Successfully Managing the TSE Crisis', Second IIR Ltd. Sponsored Symposium, London, "Insights into the mechanisms of prion propagation from transgenic mouse studies"
March 1998	Biomed 2 - Third Collaborators' Meeting, St Moritz, Switzerland, "Strains, species barriers and mechanisms of prion propagation: Studies with transgenic mice"
March 1998	Biotechnology and Biological Sciences Research Council (BBSRC) Biology of Spongiform Encephalopathies (BSEP) Workshop, University of Warwick, "Prion strains and species barriers: Studies with transgenic mice"
March 1998	‘Successfully Managing the TSE Crisis', IIR Ltd. Sponsored Symposium, London, "Insights into the mechanisms of prion propagation from Transgenic mouse studies"
Feb 1998	Royal College of Physicians, Advanced Medicine Conference, London, "BSE"
Dec 1997	Microsymposium on Prions and Prion Diseases, Institut Fur Molekularbiologie Abteilung I, Universitat Zurich, Switzerland, "Prion strains and species barriers: an update on transgenic mouse work"
Nov 1997	National Academy of Sciences' (NAS) 9 th Annual Frontiers of Science Symposium, Irvine CA, "Transgenic Models of Prion Diseases"
Sept 1997	Joint Congress of the German Societies of Clinical Chemistry and Laboratory Medicine on Molecular Diagnostics, Munster Germany, "Diagnostic markers of prion disease"
Sept 1997	The Congress of the Institute of Biomedical Science, Biomedical Science Congress, International Convention Centre, Birmingham UK, "BSE and the public health"
June 1997	National Academy of Sciences (NAS), Max-Planck-Society and the German American Academic Council's 3rd Annual German-American Frontiers of Science Symposium, Munich, Germany, *(Organizer)*
June 1997	Second Annual Centeon/ UCSF Meeting, Monterey CA, "New Models and Validation of the Transgenic Human Prion Assay"
Dec 1996	International Symposium on Spongiform Encephalopathies: Generating Rational Policy in the Face of Public Fears. The Ceres Forum of the Center for Food and Nutrition Policy at Georgetown University and the American Association of the Veterinary Medical Colleges, Georgetown University, Washington DC, "Prion Research"
Nov 1996	National Academy of Sciences' (NAS) 8th Annual Frontiers of Science Symposium, Irvine CA,
June 1996	National Academy of Sciences (NAS), German American Academic Council 2nd Annual Symposium on German-American Frontiers of Science, Woods Hole MA, "Prion Propagation and Protein X using Transgenic Mice"
May 1996	Ninety-sixth General Meeting of the American Society for Microbiology. Prion Proteins Session: "A Novel Mechanism for Inheritance", New Orleans LA, "Prion Biology and Diseases of Mammals"
April 1996	First Annual Centeon/UCSF Meeting, Napa Valley CA, "Abbreviated Assays for Human and Domestic Animal Prions"
Jan 1996	Food and Drug Administration (FDA) and the National Heart, Lung and Blood Institute (NHLBI), Bethesda MD, "Optimal methods to detect prion infectivity in human blood: Transgenic mice expressing human and chimeric human-mouse prion proteins"
Nov 1995	Symposium on the Molecular Biology of Prions and Pathology of Prion Diseases, The Banbury Center, Cold Spring Harbor Laboratory, NY, "Prion propagation and protein X in transgenic mice"
Feb 1995	Sixth International Workshop on Bovine Spongiform Encephalopathy, Williamsburg VA, "Transgenic ` mouse models of human prion diseases"
Oct 1994	Serono Symposia International Symposium on: Where genotype does not match phenotype, Volterra, Italy, "Transgenetics of prion diseases"
Aug 1993	Ninth International Congress of Virology, Glasgow, UK, "Altered patterns of expression of mutant forms of human PrP in neuroblastoma cells"
1991	Imperial Cancer Research Fund DNA Tumor Virus Symposium, Cambridge UK, "A dubious oncogene; evidence that the product of the type 5 adenovirus E1B 19K gene is not required for transformation of rodent cells"

E. Invited lectures

Oct 2007	Division of Infectious Diseases, University of Kentucky, Lexington, "Prion Diseases"
July 2007	Institut fur Virologie Technischen Universitat Munchen, Munich Germany, "Transgenic mouse models of prion diseases"
June 2007	Department of Medical Microbiology and Immunology, Creighton University, "Transgenic mouse models of prion diseases"
Sept 2006	Veterinary Laboratories Agency, United Kingdom, "Modeling prion transmission barriers in transgenic mice"
July 2006	Nathan Shock Center on Aging Seminar Series, University of Rochester School of Medicine and Dentistry, New York, "Modeling prion transmission barriers in transgenic mice"
April 2006	Department of Biological Sciences, University of Alberta, Edmonton, Canada, "Modeling prion transmission barriers in transgenic mice"
April 2006	Center for Alzheimer's Disease Research, University of Texas Medical Branch, Galveston, TX, "Modeling prion transmission barriers in transgenic mice"
Feb 2006	Department of Veterinary Science, Gluck Equine Research Center, University of Kentucky, "Transgenic mouse models of chronic wasting disease and other prion disorders"
Nov 2005	Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, "Transgenic studies of chronic wasting disease and other prion disorders"
Oct 2005	School of Veterinary Medicine, Seoul National University, Korea,"Transgenic approaches for studying prion diseases and mechanisms of prion propagation"
Oct 2005	ILSong Institute of Life Science and College of Medicine, Hallym University, Korea, "Transgenic studies of chronic wasting disease"
Sept 2005	Department of Microbiology, Miami University, Oxford, OH, "Transgenic approaches for studying prion diseases and mechanisms of prion propagation"
Sept 2005	Sanders Brown Center on Aging, University of Kentucky, "Recent breakthroughs in prion disease research"
June 2004	Department of Neurology Grand Rounds, University of Kentucky, "Recent advances in prion disease research"
May 2005	Institute of Biological Sciences and Technology, Beijing Jiaotong University, Beijing, China, "More mechanistic studies of prion propagation"
May 2005	Chinese Center for Disease Control and Prevention, Institute of Virology, Beijing, China, "Mechanistic studies of prion propagation"
May 2005	National Quarantine Institute, Key Laboratory of the Ministry of Agriculture, Tsingdao, China, "Mechanistic studies of prion propagation"
May 2005	Department of Microbiology, Shandong University, China, "Mechanistic studies of prion propagation"
May 2005	Medical School of Shandong University, China, "Transgenic studies of prion diseases and other neurodegenerative disorders of protein folding"
Feb 2005	Department of Veterinary Molecular Biology, Montana State University, Bozeman, MT, "Transgenic approaches for studying chronic wasting disease, a prion disease of cervids"
Sept 2004	Division of Infectious Diseases, University of Kentucky, Lexington, "Prions and the Prion Diseases"
April 2004	--------------------------------------------------------------------------
Mar 2004	Nathan Shock Center on Aging Seminar Series, University of Rochester School of Medicine and Dentistry, New York, "Transgenetic models of prion replication"
Jan 2004	Department of Molecular and Cellular Biochemistry, Ohio State University, "Transgenic and in vitro approaches for studying mechanisms of prion propagation"
Jan 2004	Department of Neurology Grand Rounds, University of Kentucky, "Transgenic and cell culture approaches for studying the mechanism of prion propagation"
April 2003	Department of Biochemistry and Medicine, Dartmouth Medical School, NH, "Transgenic and cell culture models of human and animal prion diseases"
June 2002	Department of Pathology and Laboratory Sciences, University of Ottawa, Canada, "Transgenic and cell culture models of human and animal prion diseases"
April 2002	Division of Infectious Diseases, University of Kentucky, Lexington, "Prions"
Nov 2001	--------------------------------- ---------------------------------
Dec 2001	Nathan Shock Center on Aging Seminar Series, University of Rochester School of Medicine and Dentistry, New York, "Transgenic and in vitro approaches for studying prion diseases "
Jan 2001	Department of Pathology, University of Kentucky, Lexington, "Prions"
Nov 2000	Department of Biological Sciences, University of Kentucky, Lexington, " Transgenic approaches for studying prion diseases"
Oct 2000	Sanders-Brown Center on Aging Seminar Series, University of Kentucky, " New transgenic and in vitro approaches for studying prion diseases "
Sept 2000	Department of Molecular and Cell Biology, University of Texas, Dallas, "Deciphering prion diseases using transgenic mice"
Feb 2000	Department of Neurology, University of Kentucky, Lexington, "Transgenic models of CJD"
Feb 2000	Department of Pathology, Case Western Reserve University, "Transgenic approaches for studying prion diseases"
April 1999	Division of Medical and Molecular Genetics, King's College at Guy's Hospital, London, "Deciphering prion diseases using transgenic mice"
April 1999	Sanders-Brown Center on Aging, University of Kentucky, Lexington, "Deciphering prion diseases using transgenic mice"
Oct 1998	Department of Molecular, Cellular and Developmental Biology, University of Colorado, "Deciphering prion diseases with transgenic mice"
Oct 1998	Department of Pathology, Colorado State University, "Deciphering prion diseases with transgenic mice"
May 1998	Institute of Animal Technology, Institute of Psychiatry, Kings College London, "Prion hypothesis"
April 1998	Institute for Animal Health, Neuropathogenesis Unit, Edinburgh, "Transgenetic investigations of TSE's"
Jan 1998	Institute of Psychiatry, Department of Neuroscience, London, "Transgenic Models of Prion Diseases"
Dec 1997	Division of Biomedical Sciences, Imperial College of Medicine at St. Mary's, "Transgenetic investigations of prion diseases"
Sept 1997	University of Birmingham, "Transgenetic investigations of prion diseases"
June 1997	Max von Pettenkofer Institut, University of Munich, Munich, Germany, "Investigating Prion Diseases with Transgenic Mice"
May 1997	University Pacific School of Dentistry, San Francisco CA, "Prion Proteins and Mad Cow Disease: Should a Dentist be Concerned?"
May 1997	University of California, Berkeley, "Prions"
Jan 1997	Neurogenetics Unit, Imperial College of Medicine at St Mary's, "Transgenic Mice and the Prion Diseases: Recent Breakthroughs and Future Directions"
Nov 1995	Departments of Biological Sciences, Carnegie Mellon University and University of Pittsburgh, Pittsburgh PA, "Prion transmission from humans to transgenic mice: Insights into the mechanisms of prion propagation"
June 1995	Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill NC, "Mechanisms of Prion Propagation from Transgenic mice expressing chimeric human-mouse prion proteins"
March 1995	------------------------------------- ----------------------------- ---------------------------- ------------------------- ----------------- ---------------------------
March 1995	Department of Biochemistry and Biophysics, University of California, San Francisco CA, "Transgenic mice for studying human prion diseases"
June 1994	Medical Research Council (MRC), Laboratory of Molecular Biology, Cambridge, UK, "Transgenic mice for studying human prion diseases"
Dec 1990	The George Williams Hooper Foundation, University of California, San Francisco CA, "Genetic analysis of the functions of the adenovirus E1 proteins in oncogenic transformation and lytic infection"